Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
20.17
+0.29 (1.48%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 50.5, with a low estimate of 26 and a high estimate of 80. The average target predicts an increase of 150.43% from the current stock price of 20.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beam Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +296.73% | Apr 7, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $42 | Hold → Strong Buy | Upgrades | $42 | +108.28% | Mar 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 12, 2025 |
| Scotiabank | Scotiabank | Hold → Buy Upgrades $40 | Hold → Buy | Upgrades | $40 | +98.36% | Mar 10, 2025 |
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $34 | Hold → Strong Buy | Upgrades | $34 | +68.61% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
60.96M
from 63.52M
Decreased by -4.02%
Revenue Next Year
64.82M
from 60.96M
Increased by 6.32%
EPS This Year
-4.90
from -4.58
EPS Next Year
-4.93
from -4.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 115.5M | 168.0M | 126.0M | ||
| Avg | 61.0M | 64.8M | 75.7M | ||
| Low | n/a | n/a | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 81.8% | 175.6% | 94.4% | ||
| Avg | -4.0% | 6.3% | 16.8% | ||
| Low | - | - | -54.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.43 | -2.87 | -3.16 | ||
| Avg | -4.90 | -4.93 | -4.94 | ||
| Low | -5.87 | -6.10 | -6.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.